Ruzadolane is primarily utilized in the field of neuroscience research, where it serves as a potent and selective antagonist for specific neurotransmitter receptors. Its application is crucial in studying the mechanisms of neurological disorders, particularly those related to glutamate signaling, such as epilepsy, neurodegenerative diseases, and chronic pain conditions. Researchers employ it to understand receptor interactions and to develop potential therapeutic agents targeting these pathways. Additionally, it is used in pharmacological studies to explore its effects on synaptic plasticity and cognitive functions, providing insights into brain health and disease management.